| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 2969984 | The Journal of Heart and Lung Transplantation | 2015 | 5 Pages |
Abstract
To our knowledge, we report the largest series of LTx recipients treated with oral ribavirin for RSV. Oral ribavirin appears to be an effective, well-tolerated alternative to IV or inhaled ribavirin; provides considerable cost savings and reduces length of hospital stay. Potential long-term benefits in preventing development of chronic lung allograft dysfunction are yet to be determined.
Keywords
Related Topics
Health Sciences
Medicine and Dentistry
Cardiology and Cardiovascular Medicine
Authors
Fay S. BPharm PGDip, Lilibeth M. BPharm, Mark MBChB, MRCP, FRACP, Deborah J.E. MBBS, BSc Med, FRACP, FRCPA, MASM, Adrian P. MBBS, PhD, FRACP, Marshall L. MBBS, MMED, PhD, FCP(SA), FRACP, Monique A. MBBS, FRACP, Allan R. MBBS, MD, FRACP,